NeoGenomics, Inc.NEONASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-2.7%
5Y CAGR-30.9%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
-2.7%/yr
vs -14.3%/yr prior
5Y CAGR
-30.9%/yr
Recent acceleration
Acceleration
+11.5pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineCompressed
PeriodValueYoY Change
20250.41-34.5%
20240.63-7.9%
20230.69+52.4%
20220.45-73.4%
20211.69-35.7%
20202.63+83.0%
20191.44+72.3%
20180.83+42.4%
20170.59+6.2%
20160.55-